Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 3
2000 5
2001 11
2002 12
2003 9
2004 23
2005 20
2006 18
2007 27
2008 18
2009 35
2010 32
2011 49
2012 51
2013 76
2014 87
2015 83
2016 102
2017 86
2018 100
2019 112
2020 120
2021 138
2022 102
2023 99
2024 160

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,383 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis.
Tan HC, Dampil OA, Marquez MM. Tan HC, et al. J ASEAN Fed Endocr Soc. 2022;37(2):65-72. doi: 10.15605/jafes.037.02.14. Epub 2022 Aug 23. J ASEAN Fed Endocr Soc. 2022. PMID: 36578889 Free PMC article. Review.
BACKGROUND: The weight loss benefit of semaglutide in patients with diabetes is well-documented, but its clinical utility in treating obesity among patients without diabetes is less described. ...CONCLUSION: Among individuals with obesity without type 2 diabe …
BACKGROUND: The weight loss benefit of semaglutide in patients with diabetes is well-documented, but its clinical utili …
Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis.
Talenezhad N, Mohammadi M, Ramezani-Jolfaie N, Mozaffari-Khosravi H, Salehi-Abargouei A. Talenezhad N, et al. Clin Nutr ESPEN. 2020 Jun;37:9-23. doi: 10.1016/j.clnesp.2020.03.008. Epub 2020 Apr 18. Clin Nutr ESPEN. 2020. PMID: 32359762 Review.
BACKGROUND AND AIM: Clinical evidence which investigated the effects of l-carnitine, a vitamin-like substance, on weight loss had led to inconsistent results. This study therefore aimed to examine the effect of l-carnitine supplementation on body weight and c …
BACKGROUND AND AIM: Clinical evidence which investigated the effects of l-carnitine, a vitamin-like substance, on weight loss
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.
Shi Q, Wang Y, Hao Q, Vandvik PO, Guyatt G, Li J, Chen Z, Xu S, Shen Y, Ge L, Sun F, Li L, Yu J, Nong K, Zou X, Zhu S, Wang C, Zhang S, Qiao Z, Jian Z, Li Y, Zhang X, Chen K, Qu F, Wu Y, He Y, Tian H, Li S. Shi Q, et al. Lancet. 2022 Jan 15;399(10321):259-269. doi: 10.1016/S0140-6736(21)01640-8. Epub 2021 Dec 8. Lancet. 2022. Retracted and republished in: Lancet. 2024 Apr 6;403(10434):e21-e31. doi: 10.1016/S0140-6736(24)00351-9 Retraction in: Lancet. 2024 Apr 6;403(10434):1321. doi: 10.1016/S0140-6736(24)00318-0 PMID: 34895470 Retracted and republished. Retracted.
We summarised the latest evidence for the benefits and harms of weight-lowering drugs. METHODS: This systematic review and network meta-analysis included searches of PubMed, Embase, and Cochrane Library (CENTRAL) from inception to March 23, 2021, for r …
We summarised the latest evidence for the benefits and harms of weight-lowering drugs. METHODS: This systematic revi
Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.
Churuangsuk C, Hall J, Reynolds A, Griffin SJ, Combet E, Lean MEJ. Churuangsuk C, et al. Diabetologia. 2022 Jan;65(1):14-36. doi: 10.1007/s00125-021-05577-2. Epub 2021 Nov 17. Diabetologia. 2022. PMID: 34796367 Free PMC article.
METHODS: First, we conducted a systematic review of published meta-analyses of RCTs of weight-loss diets. We searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews, up to 7 May 2021. ...Formula meal replaceme …
METHODS: First, we conducted a systematic review of published meta-analyses of RCTs of weight-loss diets. …
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.
Shi Q, Wang Y, Hao Q, Vandvik PO, Guyatt G, Li J, Chen Z, Xu S, Shen Y, Ge L, Sun F, Li L, Yu J, Nong K, Zou X, Zhu S, Wang C, Zhang S, Qiao Z, Jian Z, Li Y, Zhang X, Chen K, Qu F, Wu Y, He Y, Tian H, Li S. Shi Q, et al. Lancet. 2024 Apr 6;403(10434):e21-e31. doi: 10.1016/S0140-6736(24)00351-9. Lancet. 2024. PMID: 38582569
We summarised the latest evidence for the benefits and harms of weight-lowering drugs. METHODS: This systematic review and network meta-analysis included searches of PubMed, Embase, and Cochrane Library (CENTRAL) from inception to March 23, 2021, for r …
We summarised the latest evidence for the benefits and harms of weight-lowering drugs. METHODS: This systematic revi
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials.
Bikou A, Dermiki-Gkana F, Penteris M, Constantinides TK, Kontogiorgis C. Bikou A, et al. Expert Opin Pharmacother. 2024 Apr;25(5):611-619. doi: 10.1080/14656566.2024.2343092. Epub 2024 Apr 18. Expert Opin Pharmacother. 2024. PMID: 38629387 Review.
INTRODUCTION: Semaglutide, a glucagon-like peptide-1 receptor agonist, is associated with significant weight loss, yet its impact on lean body mass remains insufficiently understood. This review investigates the effect of semaglutide on lean mass in the context of o …
INTRODUCTION: Semaglutide, a glucagon-like peptide-1 receptor agonist, is associated with significant weight loss, yet its imp …
Green tea for weight loss and weight maintenance in overweight or obese adults.
Jurgens TM, Whelan AM, Killian L, Doucette S, Kirk S, Foy E. Jurgens TM, et al. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD008650. doi: 10.1002/14651858.CD008650.pub2. Cochrane Database Syst Rev. 2012. PMID: 23235664 Free PMC article. Review.
BACKGROUND: Preparations of green tea are used as aids in weight loss and weight maintenance. Catechins and caffeine, both contained in green tea, are each believed to have a role in increasing energy metabolism, which may lead to weight loss. A …
BACKGROUND: Preparations of green tea are used as aids in weight loss and weight maintenance. Catechins and caffeine, b …
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
He L, Wang J, Ping F, Yang N, Huang J, Li Y, Xu L, Li W, Zhang H. He L, et al. JAMA Intern Med. 2022 May 1;182(5):513-519. doi: 10.1001/jamainternmed.2022.0338. JAMA Intern Med. 2022. PMID: 35344001 Free PMC article.
IMPORTANCE: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been widely recommended for glucose control and cardiovascular risk reduction in patients with type 2 diabetes, and more recently, for weight loss. However, the associations of GLP-1 RAs with gal …
IMPORTANCE: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been widely recommended for glucose control and cardiovascular risk r …
Systematic Review of the Mediterranean Diet for Long-Term Weight Loss.
Mancini JG, Filion KB, Atallah R, Eisenberg MJ. Mancini JG, et al. Am J Med. 2016 Apr;129(4):407-415.e4. doi: 10.1016/j.amjmed.2015.11.028. Epub 2015 Dec 22. Am J Med. 2016. PMID: 26721635 Review.
We therefore conducted a systematic review of randomized controlled trials (RCTs) to determine the effect of the Mediterranean diet on weight loss and cardiovascular risk factor levels after 12 months. ...The Mediterranean diet resulted i …
We therefore conducted a systematic review of randomized controlled trials (RCTs) to determine the effect of the Mediterranean …
Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systematic Review.
Álvarez-Arraño V, Martín-Peláez S. Álvarez-Arraño V, et al. Nutrients. 2021 Oct 17;13(10):3627. doi: 10.3390/nu13103627. Nutrients. 2021. PMID: 34684633 Free PMC article.
Intestinal microbiota has been shown to be a potential determining factor in the development of obesity. The objective of this systematic review is to collect and learn, based on the latest available evidence, the effect of the use of probiotics and synbiotics in ra …
Intestinal microbiota has been shown to be a potential determining factor in the development of obesity. The objective of this systematic
1,383 results